Analytical Qualification of the BD‐Tau Xplorer kit on LUMIPULSE® G1200
The BD-Tau Xplorer kit provides accurate and reproducible quantification of BD-Tau on an automated platform. Further validation in larger and more differentiated cohorts is warranted to evaluate its context of use and value as a potential marker for prognosis and monitoring disease progression, not only in AD but across neurological diseases.
Authors
- Jeroen Vanbrabant
- Inge M.W. Verberk
- W. M. van der Flier
- Daniel Antwi‐Berko
- Charlotte E. Teunissen
- Erik Stoops
- Nathan Blancke
- Maxime Van Loo
Institutions
- Amsterdam Neuroscience (NL)
- ADx NeuroSciences (BE)
- ADx NeuroSciences
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_105432
- Primary Topic
- Prion Diseases and Protein Misfolding
- Type
- article
- Field-Weighted Citation Impact
- 0.00